Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 109, Issue -, Pages 22-29
Publisher
Wiley
Online
2012-01-12
DOI
10.1111/j.1464-410x.2011.10827.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progresión metastática, mortalidad cáncer específica y necesidad de tratamientos de segunda línea en pacientes con cáncer de próstata de alto riesgo tratados inicialmente mediante prostatectomía radical
- (2013) J. Rubio-Briones et al. Actas Urologicas Espanolas
- The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition
- (2012) Antonio Cassio Assis Pellizzon et al. International Journal of Medical Sciences
- Comparison of Tumor Control and Toxicity Outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients With Favorable Risk Prostate Cancer
- (2011) Michael J. Zelefsky et al. UROLOGY
- Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapy
- (2010) Gregory S. Merrick et al. BJU INTERNATIONAL
- Biochemical Recurrence Following Robot-Assisted Radical Prostatectomy: Analysis of 1384 Patients with a Median 5-year Follow-up
- (2010) Mani Menon et al. EUROPEAN UROLOGY
- Young Men Have Equivalent Biochemical Outcomes Compared With Older Men After Treatment With Brachytherapy for Prostate Cancer
- (2010) Ryan J. Burri et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ten-Year Outcomes: The Clinical Utility of Single Photon Emission Computed Tomography/Computed Tomography Capromab Pendetide (Prostascint) in a Cohort Diagnosed With Localized Prostate Cancer
- (2010) Rodney J. Ellis et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09
- (2010) Anthony L. Zietman et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10years
- (2010) Nicholas P. Munro et al. RADIOTHERAPY AND ONCOLOGY
- Five Year Biochemical Recurrence Free Survival for Intermediate Risk Prostate Cancer After Radical Prostatectomy, External Beam Radiation Therapy or Permanent Seed Implantation
- (2010) Andrew D. Vassil et al. UROLOGY
- Long-term Survival After Radical Prostatectomy for Men With High Gleason Sum in Pathologic Specimen
- (2010) Phillip M. Pierorazio et al. UROLOGY
- Outcomes After Radical Prostatectomy Among Men Who Are Candidates for Active Surveillance: Results From the SEARCH Database
- (2010) Christopher J. Kane et al. UROLOGY
- Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy
- (2010) Michael Dattoli et al. Journal of Oncology
- Excellent Results From High Dose Rate Brachytherapy and External Beam for Prostate Cancer are Not Improved by Androgen Deprivation
- (2009) D Jeffrey Demanes et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy
- (2009) Richard G. Stock et al. BJU INTERNATIONAL
- Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy
- (2009) Alice Y. Ho et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A Single-Institution Matched-Pair Analysis
- (2009) Tom Pickles et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long-Term Biochemical and Survival Outcome of 921 Patients Treated With I-125 Permanent Prostate Brachytherapy
- (2009) Karel A. Hinnen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Natural History of Clinically Staged Low- and Intermediate-Risk Prostate Cancer Treated With Monotherapeutic Permanent Interstitial Brachytherapy
- (2009) Al V. Taira et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Whole-Pelvis Radiotherapy in Combination With Interstitial Brachytherapy: Does Coverage of the Pelvic Lymph Nodes Improve Treatment Outcome in High-Risk Prostate Cancer?
- (2009) Nathan Bittner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Equivalent Biochemical Control and Improved Prostate-Specific Antigen Nadir After Permanent Prostate Seed Implant Brachytherapy Versus High-Dose Three-Dimensional Conformal Radiotherapy and High-Dose Conformal Proton Beam Radiotherapy Boost
- (2009) Siavash Jabbari et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Local Control Following Permanent Prostate Brachytherapy: Effect of High Biologically Effective Dose on Biopsy Results and Oncologic Outcomes
- (2009) Nelson N. Stone et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Population-based Study of Biochemical and Survival Outcomes After Permanent 125I Brachytherapy for Low- and Intermediate-risk Prostate Cancer
- (2009) W.J. Morris et al. UROLOGY
- Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study
- (2009) C. Giberti et al. WORLD JOURNAL OF UROLOGY
- Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer
- (2008) Paul L. Nguyen et al. CANCER
- Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate Cancer
- (2008) Michael J. Zelefsky et al. EUROPEAN UROLOGY
- Primary Causes of Death After Permanent Prostate Brachytherapy
- (2008) Nathan Bittner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long-Term Results of Conformal Radiotherapy for Prostate Cancer: Impact of Dose Escalation on Biochemical Tumor Control and Distant Metastases-Free Survival Outcomes
- (2008) Michael J. Zelefsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy
- (2008) Stephen A. Boorjian et al. JOURNAL OF UROLOGY
- The Specific Definition of High Risk Prostate Cancer Has Minimal Impact on Biochemical Relapse-Free Survival
- (2008) Carvell T. Nguyen et al. JOURNAL OF UROLOGY
- Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy?
- (2008) Eric A. Klein et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Limited Pelvic Lymph Node Dissection Does Not Improve Biochemical Relapse-Free Survival at 10 Years After Radical Prostatectomy in Patients with Low-Risk Prostate Cancer
- (2008) Christopher J. Weight et al. UROLOGY
- Ten-Year Biochemical Disease Control for Patients with Prostate Cancer Treated with Cryosurgery as Primary Therapy
- (2008) Jeffrey K. Cohen et al. UROLOGY
- Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer
- (2007) Deborah A. Kuban et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started